Cargando…

Comparative pharmacokinetics of fluralaner in dogs and cats following single topical or intravenous administration

BACKGROUND: Bravecto™ Chewable Tablets for Dogs, containing fluralaner as active ingredient, is an innovative treatment for flea and tick infestations that provides safe, rapid and long acting efficacy after a single oral administration in dogs. Topically applied fluralaner provides similar safe, ra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kilp, Susanne, Ramirez, Diana, Allan, Mark J, Roepke, Rainer KA
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4886404/ https://www.ncbi.nlm.nih.gov/pubmed/27241240 http://dx.doi.org/10.1186/s13071-016-1564-8

Ejemplares similares

Pharmacokinetics of fluralaner in dogs following a single oral or intravenous administration
por: Kilp, Susanne, et al.
Publicado: (2014)

Plasma pharmacokinetic profile of fluralaner (Bravecto™) and ivermectin following concurrent administration to dogs
por: Walther, Feli M., et al.
Publicado: (2015)

The effect of food on the pharmacokinetics of oral fluralaner in dogs
por: Walther, Feli M, et al.
Publicado: (2014)

Safety of topical administration of fluralaner plus moxidectin concurrently with praziquantel in cats
por: Walther, Feli M., et al.
Publicado: (2018)

Efficacy of fluralaner against Otodectes cynotis infestations in dogs and cats
por: Taenzler, Janina, et al.
Publicado: (2017)

Safety of concurrent treatment of cats with fluralaner and emodepsid–praziquantel
por: Walther, Feli M., et al.
Publicado: (2016)

Prevention of transmission of Babesia canis by Dermacentor reticulatus ticks to dogs after topical administration of fluralaner spot-on solution
por: Taenzler, Janina, et al.
Publicado: (2016)

Erratum to: Safety of concurrent treatment of cats with fluralaner and emodepsid-praziquantel
por: Walther, Feli M., et al.
Publicado: (2016)

Safety of fluralaner chewable tablets (Bravecto(TM)), a novel systemic antiparasitic drug, in dogs after oral administration
por: Walther, Feli M, et al.
Publicado: (2014)

Safety of concurrent treatment of dogs with fluralaner (Bravecto™) and milbemycin oxime - praziquantel
por: Walther, Feli M, et al.
Publicado: (2014)

Onset of activity of fluralaner (BRAVECTO™) against Ctenocephalides felis on dogs
por: Taenzler, Janina, et al.
Publicado: (2014)

Safety of fluralaner, a novel systemic antiparasitic drug, in MDR1(-/-) Collies after oral administration
por: Walther, Feli M, et al.
Publicado: (2014)

The speed of kill of fluralaner (Bravecto™) against Ixodes ricinus ticks on dogs
por: Wengenmayer, Christina, et al.
Publicado: (2014)

Safety of the concurrent treatment of dogs with Bravecto™ (fluralaner) and Scalibor™ protectorband (deltamethrin)
por: Walther, Feli M, et al.
Publicado: (2014)

Efficacy of orally and topically administered fluralaner (Bravecto(®)) for treatment of client-owned dogs with sarcoptic mange under field conditions
por: Chiummo, Rafael, et al.
Publicado: (2020)

A randomized, blinded, controlled and multi-centered field study comparing the efficacy and safety of Bravecto™ (fluralaner) against Frontline™ (fipronil) in flea- and tick-infested dogs
por: Rohdich, Nadja, et al.
Publicado: (2014)

Efficacy of fluralaner administered either orally or topically for the treatment of naturally acquired Sarcoptes scabiei var. canis infestation in dogs
por: Taenzler, Janina, et al.
Publicado: (2016)

Efficacy of fluralaner plus moxidectin (Bravecto® Plus spot-on solution for cats) against Otodectes cynotis infestations in cats
por: Taenzler, Janina, et al.
Publicado: (2018)

Prevention of transmission of Babesia canis by Dermacentor reticulatus ticks to dogs treated orally with fluralaner chewable tablets (Bravecto™)
por: Taenzler, Janina, et al.
Publicado: (2015)

A quantitative evaluation of the extent of fluralaner uptake by ticks (Ixodes ricinus, Ixodes scapularis) in fluralaner (Bravecto(TM)) treated vs. untreated dogs using the parameters tick weight and coxal index
por: Williams, Heike, et al.
Publicado: (2015)

A single topical fluralaner application to cats and to dogs controls fleas for 12 weeks in a simulated home environment
por: Ranjan, Sivaja, et al.
Publicado: (2018)

Efficacy of fluralaner spot-on solution against induced infestations with Rhipicephalus sanguineus on dogs
por: Taenzler, Janina, et al.
Publicado: (2016)

Efficacy of topically administered fluralaner or imidacloprid/moxidectin on dogs with generalised demodicosis
por: Fourie, Josephus J., et al.
Publicado: (2019)

The effect of water and shampooing on the efficacy of fluralaner spot-on solution against Ixodes ricinus and Ctenocephalides felis infestations in dogs
por: Taenzler, Janina, et al.
Publicado: (2016)

Flea and tick treatment satisfaction, preference, and adherence of US cat owners prescribed topical fluralaner (Bravecto(®) Topical Solution for Cats)
por: Lavan, Robert, et al.
Publicado: (2021)

A European field assessment of the efficacy of fluralaner (Bravecto(®)) chewable and spot-on formulations for treatment of dogs with generalized demodicosis
por: Petersen, Ivo, et al.
Publicado: (2020)

Efficacy of Bravecto(®) Plus spot-on solution for cats (280 mg/ml fluralaner and 14 mg/ml moxidectin) for the prevention of aelurostrongylosis in experimentally infected cats
por: Raue, Katharina, et al.
Publicado: (2021)

Pharmacokinetics of lotilaner following a single oral or intravenous administration in cats
por: Toutain, Céline E., et al.
Publicado: (2018)

Fluralaner activity against life stages of ticks using Rhipicephalus sanguineus and Ornithodoros moubata IN in vitro contact and feeding assays
por: Williams, Heike, et al.
Publicado: (2015)

Posaconazole Pharmacokinetics in Healthy Cats after Oral and Intravenous Administration
por: Mawby, D.I., et al.
Publicado: (2016)

Pharmacokinetics of isavuconazole in healthy cats after oral and intravenous administration
por: Woerde, Dennis J., et al.
Publicado: (2022)

In-home assessment of either topical fluralaner or topical selamectin for flea control in naturally infested cats in West Central Florida, USA
por: Dryden, Michael W., et al.
Publicado: (2018)

Pharmacokinetics of BMEDA after Intravenous Administration in Beagle Dogs
por: Chang, Chih-Hsien, et al.
Publicado: (2014)

Pharmacokinetics and Immunogenicity of Frunevetmab in Osteoarthritic Cats Following Intravenous and Subcutaneous Administration
por: Walters, Rodney R., et al.
Publicado: (2021)

Plasma pharmacokinetics of tigolaner, emodepside, and praziquantel following topical administration of a combination product (Felpreva®) and of intravenous administration of the individual active ingredients in cats
por: Mencke, Norbert, et al.
Publicado: (2023)

Topical or oral fluralaner efficacy against flea (Ctenocephalides felis) transmission of Dipylidium caninum infection to dogs
por: Gopinath, Deepa, et al.
Publicado: (2018)

Pharmacokinetics of esomeprazole following intravenous and oral administration in healthy dogs
por: Cook, Emily K, et al.
Publicado: (2016)

Field effectiveness and safety of fluralaner plus moxidectin (Bravecto® Plus) against ticks and fleas: a European randomized, blinded, multicenter field study in naturally-infested client-owned cats
por: Rohdich, Nadja, et al.
Publicado: (2018)

Pharmacokinetics of Mycophenolic Acid after Intravenous Administration of Mycophenolate Mofetil to Healthy Cats
por: Slovak, J.E., et al.
Publicado: (2017)

Comparative efficacy of oral administrated afoxolaner (NexGard™) and fluralaner (Bravecto™) with topically applied permethrin/imidacloprid (Advantix(®)) against transmission of Ehrlichia canis by infected Rhipicephalus sanguineus ticks to dogs
por: Jongejan, Frans, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_gc7v98no5rsu269uiddk6ctcb9